HSBC Holdings’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$627K Buy
161,510
+23,528
+17% +$119K ﹤0.01% 2108
2025
Q4
$941K Sell
137,982
-1,808
-1% -$12.7K ﹤0.01% 1974
2025
Q3
$966K Sell
139,790
-13,520
-9% -$94K ﹤0.01% 1809
2025
Q2
$943K Buy
153,310
+113,842
+288% +$757K ﹤0.01% 1833
2025
Q1
$295K Buy
39,468
+9,756
+33% +$81.5K ﹤0.01% 2385
2024
Q4
$283K Sell
29,712
-13,207
-31% -$103K ﹤0.01% 2527
2024
Q3
$251K Buy
42,919
+8,576
+25% +$56.8K ﹤0.01% 2470
2024
Q2
$233K Buy
34,343
+2,329
+7% +$16.4K ﹤0.01% 2458
2024
Q1
$247K Buy
32,014
+8,215
+35% +$66K ﹤0.01% 2563
2023
Q4
$211K Buy
23,799
+4,344
+22% +$31.8K ﹤0.01% 2449
2023
Q3
$143K Buy
+19,455
New +$145K ﹤0.01% 2490
2017
Q1
Sell
-19,845
Closed -$176K 2392
2016
Q4
$176K Buy
+19,845
New +$178K ﹤0.01% 2551

Other funds holding MDXG

HSBC Holdings's MDXG Position: Q1 2026 in Review

HSBC Holdings increased its MiMedx Group (MDXG) stake by 17% in Q1 2026, buying an estimated $119K and bringing the position to 161,510 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

HSBC Holdings first reported a position in MDXG in Q4 2016 and has held it in 12 quarters since. The position peaked at $966K in Q3 2025. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • HSBC Holdings held 161,510 shares of MiMedx Group worth $627K as of Q1 2026.
  • HSBC Holdings bought 23,528 MiMedx Group shares in Q1 2026, an estimated $119K.
  • MiMedx Group made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2108 holding.
  • HSBC Holdings first reported a position in MiMedx Group in Q4 2016 and has held it in 12 quarters since.
  • HSBC Holdings's MiMedx Group position peaked at $966K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.